Xiaoxian Li MD, PhD

Contact Information:

Email: bill.li@emory.edu

View Emory directory entry

School/Division:

Assoc Professor

SOM: Pathology: Admin

School Of Medicine

Other Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site, iTunes lectures, etc.):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 12

  1. 1
  2. 2

Article

Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancer

by Angela Ogden; Chakravarthy Garlapati; Xiaoxian Li; Ravi Chakra Turaga; Gabriela Oprea; Nikita Wright; Shristi Bhattarai; Karuna Mittal; Ceyda Sönmez Wetherilt; Uma Krishnamurti; Michelle Reid; Mildred Jones; Meenakshi Gupta; Remus Osan; Sonal Pattni; Ansa Riaz; Sergey Klimov; Arundhati Rao; Guilherme Cantuaria; Padmashree C. G. Rida; Ritu Aneja

2017

Article

A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations

by Xiaoxian Li; TP Reddy; RR Rosato; S Moulder; H Piwnica-Worms; JC Chang

2020

Article

A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)

by Tejal A. Patel; Joe E. Ensor; Sarah L. Creamer; Toniva Boone; Angel A. Rodriguez; Poly A. Niravath; Jorge G. Darcourt; Jane L. Meisel; Xiaoxian Li; Jing Zhao; John G. Kuhn; Roberto R. Rosato; Wei Qian; Anna Belcheva; Mary R. Schwartz; Virginia G. Kaklamani; Jenny C. Chang

2019

Article

Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study

by Shristi Bhattarai; Sergey Klimov; Karuna Mittal; Uma Krishnamurti; Xiaoxian Li; Gabriela Oprea; Ceyda Sonmez Wetherilt; Ansa Riaz; Mohammed A. Aleskandarany; Andrew R. Green; Ian O. Ellis; Guilherme Cantuaria; Meenakshi Gupta; Upender Manne; Johnson Agboola; Brett Baskovich; Emiel A. M. Janssen; Grace Callagy; Elaine M. Walsh; Anurag Mehta; Atika Dogra; Tanuja Shet; Pooja Gajaria; Tiffany Traina; Haruna A. Nggada; Abidemi Omonisi; Saad A. Ahmed; Emad A. Rakha; Padmashree Rida; Ritu Aneja

2019

Article

Role of RPL39 in Metaplastic Breast Cancer

by Bhuvanesh Dave; Daniel D. Gonzalez; Zhi-Bin Liu; Xiaoxian Li; Helen Wong; Sergio Granados; Nadeer E. Ezzedine; Douglas H. Sieglaff; Joe E. Ensor; Kathy D. Miller; Milan Radovich; Agda KarinaEtrovic; Steven S. Gross; Olivier Elemento; Gordon B. Mills; Michael Z. Gilcrease; Jenny C. Chang

2017

Article

CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy.

by Ashley J. Schlafstein; Allison E. Withers; Soumon Rudra; Diana Danelia; Jeffrey Switchenko; Donna Mister; Saul Harari; Hui Zhang; Waaqo Daddacha; Shahrzad Ehdaivand; Xiaoxian Li; Mylin Torres; David Yu

2018

Article

An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model

by Matthew Jennis; Che-Pei Kung; Subhasree Basu; Anna Budina-Kolomets; Julia I-Ju Leu; Sakina Khaku; Jeremy P. Scott; Kathy Q. Cai; Michelle R. Campbell; Devin K. Porter; Xuting Wang; Douglas A. Bell; Xiaoxian Li; David S. Garlick; Qin Liu; Monica Hollstein; Donna L. George; Maureen E. Murphy

2016

Article

Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers

by Vaishali Pannu; Karuna Mittal; Guilherme Cantuaria; Michelle Reid; Xiaoxian Li; Shashikiran Donthamsetty; Michelle McBride; Sergey Klimov; Remus Osan; Meenaskhi V. Gupta; Padmashree C. G. Rida; Ritu Aneja

2015